Skip to main content
Clinical Trials/CTRI/2020/08/027367
CTRI/2020/08/027367
Not yet recruiting
未知

Evaluation of pharmacokinetic profile of Levetiracetam in different trimesters of pregnancy, correlation with clinical outcome by therapeutic drug monitoring : a prospective study

PGIMER0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
PGIMER
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
PGIMER

Eligibility Criteria

Inclusion Criteria

  • 1\. Pregnant women with confirmed diagnosis of epilepsy and on stable dose of
  • levetiracetam throughout gestation period
  • 2\. Subject on a stable dose of one or two antiepileptic drugs during baseline.
  • 3\. Participants willing to provide written informed consent.

Exclusion Criteria

  • Patients with unstable medical conditions like renal and hepatic insufficiency and history of neuropsychiatric disorder.

Outcomes

Primary Outcomes

Not specified

Similar Trials